Lab Reagents
Ige Antibody Laboratories manufactures the ige and igg4 antibodies reagents distributed by Genprice. The Ige And Igg4 Antibodies reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ige antibody. Other Ige products are available in stock. Specificity: Ige Category: And Group: Igg4 Antibodies
Human IgG4 |
|||
C040333-1mg | Unibiotest | 1mg | EUR 931.2 |
IgG4 Antibody |
|||
DF12638 | Affbiotech | 200ul | EUR 420 |
IgG4 Antibody |
|||
48893-100ul | SAB | 100ul | EUR 399.6 |
IgG4 Antibody |
|||
48893-50ul | SAB | 50ul | EUR 286.8 |
IgE |
|||
E3M00010 | EnoGene | 200ul | EUR 489.6 |
Human Immunoglobulin G4-Fc (IgG4-Fc) AssayLite Multi-Color Conjugated Antibodies Flow Cytometry Kit |
|||
FACS34108M | AssayPro | Kit | EUR 831.6 |
IgE/ Rat IgE ELISA Kit |
|||
ELA-E0545r | Lifescience Market | 96 Tests | EUR 1063.2 |
Immuno Diluent and Block (Clear), 125 ml; For diluting and storing antibodies |
|||
NB307-C | Innovex | 125 ml | EUR 456 |
IgG4 Conjugated Antibody |
|||
C48893 | SAB | 100ul | EUR 476.4 |
Human IgG4 Antibody |
|||
48305-100ul | SAB | 100ul | EUR 399.6 |
Human IgG4 Antibody |
|||
48305-50ul | SAB | 50ul | EUR 286.8 |
Human IgG4 protein |
|||
31-1009 | Fitzgerald | 100 ug | EUR 346.8 |
Description: Purified Normal Human plasma IgG4 protein |
Anti-IgG4 antibody |
|||
STJ180132 | St John's Laboratory | 0.1 ml | EUR 254.4 |
Human IgG4 Antibody |
|||
RQ4982 | NSJ Bioreagents | 100ul | EUR 419 |
Human IgG4 Antibody |
|||
V3454-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells. |
Human IgG4 Antibody |
|||
V3454-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells. |
Human IgG4 Antibody |
|||
V3454SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: The regions of relatively constant sequence beyond the variable regions of immunoglobulins are termed constant regions (C regions) and are present in both the heavy and light chains. With very few exceptions, the sites of attachment for carbohydrates on immunoglobulins are located in these C regions. These regions also function to hold the variable regions together by using the disulfide bond between them. The C regions facilitate interaction with the antigen by increasing the maximum rotation of the immunoglobulin arms. Reportedly, a large population of patients with recurrent respiratory tract infection has low IgG4 concentrations. IgG4-related sclerosing disease has been recognized as a systemic disease entity characterized by an elevated serum IgG4 level, sclerosing fibrosis, and diffuse lymphoplasmacytic infiltration with the presence of many IgG4-positive plasma cells. IgG4 is overexpressed in inflammatory pseudotumor (IPT) and under expressed in inflammatory myofibroblastic tumor (IMT). In pulmonary nodular lymphoid hyperplasia (PNLH), there are an increased number of IgG4+ plasma cells. |